Clinical analysis of prophylactic cholecystectomy during gastrectomy for gastric cancer patients: a retrospective study of 1753 patients.
Adult
Aged
Aged, 80 and over
Body Mass Index
Cholecystectomy
Cholecystolithiasis
/ prevention & control
Diabetes Complications
Female
Gastrectomy
/ methods
Gastroenterostomy
Humans
Male
Middle Aged
Postoperative Complications
Prophylactic Surgical Procedures
Retrospective Studies
Risk Factors
Stomach Neoplasms
/ surgery
Cholecystolithiasis
Gastric cancer
Prophylactic cholecystectomy
Subtotal gastrectomy
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
14 May 2019
14 May 2019
Historique:
received:
08
07
2018
accepted:
03
05
2019
entrez:
16
5
2019
pubmed:
16
5
2019
medline:
24
5
2019
Statut:
epublish
Résumé
Performance of gastrectomy in gastric cancer patients can lead to an increased incidence of cholecystolithiasis (CL) and a higher morbidity rate. However, the value of prophylactic cholecystectomy performed during gastric cancer surgery is still being debated. We carried out a retrospective study on patients with gastric cancer who underwent subtotal or total gastrectomy, with preservation of the gallbladder or simultaneous cholecystectomy from January 2010 to March 2018. Cholecystolithiasis occurred in 152 of 1691 (8.98%) patients after gastric cancer surgery, with 45 (2.67%) patients undergoing subsequent cholecystectomy. Postoperative body mass index (BMI) decrease > 5% in 3 months was an independent risk factor for cholecystolithiasis [BMI decrease > 5%/≤5%: OR (95%CI): 1.812 (1.225-2.681), p = 0.003). Gastrectomy method and diabetes mellitus were independent risk factors for both cholecystolithiasis [gastrectomy method (no-Billroth I/Billroth I): OR (95%CI): 1.801 (1.097-2.959), p = 0.002; diabetes mellitus (yes/no): OR (95%CI): 1.544 (1.030-2.316), p = 0.036] and subsequent cholecystectomy [gastrectomy method (no-Billroth I/Billroth I): OR (95%CI): 5.432 (1.309-22.539), p = 0.020; diabetes mellitus (yes/no): OR (95%CI): 2.136 (1.106-4.125), p = 0.024]. Simultaneous cholecystectomy was performed in 62 of 1753 (3.5%) patients. The mortality and morbidity rates did not differ significantly between the combined surgery group and the gastrectomy only group (8.1% vs. 8.9 and 1.6% vs. 2.2%, respectively, p > 0.05). Prophylactic cholecystectomy may be necessary in gastric cancer patients without Billroth I gastrectomy and with diabetes mellitus. Simultaneous cholecystectomy during gastric cancer surgery does not increase the postoperative mortality and morbidity rates.
Sections du résumé
BACKGROUND
BACKGROUND
Performance of gastrectomy in gastric cancer patients can lead to an increased incidence of cholecystolithiasis (CL) and a higher morbidity rate. However, the value of prophylactic cholecystectomy performed during gastric cancer surgery is still being debated.
METHODS
METHODS
We carried out a retrospective study on patients with gastric cancer who underwent subtotal or total gastrectomy, with preservation of the gallbladder or simultaneous cholecystectomy from January 2010 to March 2018.
RESULTS
RESULTS
Cholecystolithiasis occurred in 152 of 1691 (8.98%) patients after gastric cancer surgery, with 45 (2.67%) patients undergoing subsequent cholecystectomy. Postoperative body mass index (BMI) decrease > 5% in 3 months was an independent risk factor for cholecystolithiasis [BMI decrease > 5%/≤5%: OR (95%CI): 1.812 (1.225-2.681), p = 0.003). Gastrectomy method and diabetes mellitus were independent risk factors for both cholecystolithiasis [gastrectomy method (no-Billroth I/Billroth I): OR (95%CI): 1.801 (1.097-2.959), p = 0.002; diabetes mellitus (yes/no): OR (95%CI): 1.544 (1.030-2.316), p = 0.036] and subsequent cholecystectomy [gastrectomy method (no-Billroth I/Billroth I): OR (95%CI): 5.432 (1.309-22.539), p = 0.020; diabetes mellitus (yes/no): OR (95%CI): 2.136 (1.106-4.125), p = 0.024]. Simultaneous cholecystectomy was performed in 62 of 1753 (3.5%) patients. The mortality and morbidity rates did not differ significantly between the combined surgery group and the gastrectomy only group (8.1% vs. 8.9 and 1.6% vs. 2.2%, respectively, p > 0.05).
CONCLUSIONS
CONCLUSIONS
Prophylactic cholecystectomy may be necessary in gastric cancer patients without Billroth I gastrectomy and with diabetes mellitus. Simultaneous cholecystectomy during gastric cancer surgery does not increase the postoperative mortality and morbidity rates.
Identifiants
pubmed: 31088424
doi: 10.1186/s12893-019-0512-x
pii: 10.1186/s12893-019-0512-x
pmc: PMC6515595
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
48Références
Eur J Epidemiol. 1999 Mar;15(3):245-51
pubmed: 10395054
World J Surg. 2005 Feb;29(2):182-6
pubmed: 15654665
Eur Surg Res. 2005 Jan-Feb;37(1):29-35
pubmed: 15818039
Nat Med. 2008 Jul;14(7):778-82
pubmed: 18587407
J Gastrointest Surg. 2009 May;13(5):886-9
pubmed: 19219514
World J Surg. 2010 May;34(5):1008-14
pubmed: 20135313
Int J Surg. 2013;11(4):305-8
pubmed: 23434939
J Visc Surg. 2013 Sep;150(4):229-35
pubmed: 23916848
Int J Surg. 2014 Dec;12(12):1357-9
pubmed: 25448658
Medicine (Baltimore). 2016 Apr;95(15):e3157
pubmed: 27082555
Gastric Cancer. 2017 Sep;20(5):895-903
pubmed: 28154944
World J Surg. 2017 Oct;41(10):2642
pubmed: 28255625
Gastric Cancer. 2018 May;21(3):516-523
pubmed: 29127549
Indian J Cancer. 2017 Jan-Mar;54(1):43-46
pubmed: 29199661
Br J Surg. 1988 Sep;75(9):899-900
pubmed: 3179669
Surgery. 1988 May;103(5):579-83
pubmed: 3283982